Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Subcommittee weighs HB 554 to broaden insurer coverage for licensed nonopioid pain therapies
Summary
An interim subcommittee reviewed House Bill 554, agreeing to define 'pain' as patient‑centered (removing a durational 'chronic' label), narrow covered therapies to licensed providers, and pursue stakeholder talks with insurers before formal drafting; next steps include circulating a consolidated draft and reconvening before the October interim report deadline.
The Health, Human Services and Elderly Affairs interim study subcommittee met to consider House Bill 554, legislation intended to expand patient access to licensed, nonopioid pain treatments by clarifying definitions and insurer obligations.
The chair opened the session saying the bill’s purpose is to "increase access to therapies that we know have value," framing the measure as a response to gaps revealed during the opioid crisis and to inconsistent insurer coverage. The bill’s prime sponsor, David Lundgren, was noted as present.
Members focused first on the statutory definition of pain. The committee heard that the International Association for the Study of Pain updated its definition in 2020; the chair and other members proposed inserting "patient centered" into the bill and dropping a separate durational definition of "chronic pain" for this enactment. "If we define pain as patient centered, we probably have done enough for the legislative element of it," the chair…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
